IRIS PubliCatt

D'Alo', Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.897
EU - Europa 4.397
AS - Asia 1.606
OC - Oceania 150
AF - Africa 60
SA - Sud America 49
Continente sconosciuto - Info sul continente non disponibili 2
Totale 11.161
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.784
DE - Germania 1.671
CN - Cina 897
SE - Svezia 655
IT - Italia 537
UA - Ucraina 299
SG - Singapore 298
GB - Regno Unito 237
PL - Polonia 234
FR - Francia 197
IE - Irlanda 155
AU - Australia 129
IN - India 125
FI - Finlandia 101
CA - Canada 100
ID - Indonesia 97
RU - Federazione Russa 66
TR - Turchia 47
NL - Olanda 32
CI - Costa d'Avorio 26
BE - Belgio 25
IR - Iran 25
RO - Romania 23
CH - Svizzera 22
NZ - Nuova Zelanda 21
ES - Italia 20
BR - Brasile 19
JP - Giappone 18
VN - Vietnam 15
AT - Austria 14
CZ - Repubblica Ceca 14
KR - Corea 14
HU - Ungheria 13
IL - Israele 11
AR - Argentina 10
MX - Messico 10
NO - Norvegia 10
PT - Portogallo 10
GR - Grecia 8
MY - Malesia 8
SK - Slovacchia (Repubblica Slovacca) 8
AE - Emirati Arabi Uniti 7
BG - Bulgaria 7
CL - Cile 7
DZ - Algeria 7
EG - Egitto 7
HK - Hong Kong 7
LT - Lituania 7
ZA - Sudafrica 7
CO - Colombia 6
HR - Croazia 6
BA - Bosnia-Erzegovina 5
LB - Libano 5
SA - Arabia Saudita 5
TH - Thailandia 5
DK - Danimarca 4
MA - Marocco 4
MK - Macedonia 4
NP - Nepal 4
BY - Bielorussia 3
EC - Ecuador 3
GH - Ghana 3
LV - Lettonia 3
PK - Pakistan 3
RS - Serbia 3
TN - Tunisia 3
DO - Repubblica Dominicana 2
EE - Estonia 2
GE - Georgia 2
IS - Islanda 2
JO - Giordania 2
LY - Libia 2
QA - Qatar 2
UY - Uruguay 2
A1 - Anonimo 1
BD - Bangladesh 1
BO - Bolivia 1
EU - Europa 1
IQ - Iraq 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MM - Myanmar 1
PH - Filippine 1
PR - Porto Rico 1
PY - Paraguay 1
SC - Seychelles 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 11.161
Salva come PNG Salva come JPEG
Città #
Chandler 665
Ashburn 315
Singapore 240
Jacksonville 232
Warsaw 208
Beijing 188
Houston 160
Nanjing 157
Dublin 149
Dearborn 147
San Mateo 146
Ann Arbor 140
Woodbridge 137
Fairfield 129
Wilmington 113
Milan 109
Nürnberg 108
Hangzhou 103
New York 100
Redwood City 95
Seattle 89
Jakarta 88
Rome 84
Bremen 70
Munich 66
Chicago 63
Los Angeles 60
Nanchang 58
Cattolica 53
Moscow 53
Lawrence 52
Boston 48
Helsinki 37
Marseille 37
Kunming 36
Izmir 35
Sydney 32
Cambridge 31
Lancaster 30
Guangzhou 27
Shenyang 27
Abidjan 26
Shanghai 25
London 24
Princeton 23
Adelaide 22
Brisbane 22
Portland 22
Phoenix 21
Brussels 20
Hebei 20
Hefei 20
Leawood 20
Melbourne 20
Auburn Hills 19
Changsha 19
Fremont 19
Jiaxing 18
Mountain View 18
Brooklyn 17
Redmond 17
Boardman 16
University Park 16
Zhengzhou 16
Philadelphia 15
San Diego 15
San Francisco 15
Tianjin 15
Norwalk 14
Toronto 14
Augusta 13
Berlin 13
Jinan 13
Buffalo 11
Pune 11
Costa Mesa 10
Hanoi 10
Naples 10
Pittsburgh 10
Atlanta 9
Auckland 9
Chengdu 9
Hermosillo 9
Kansas City 9
Lanzhou 9
Padova 9
Brno 8
Detroit 8
Falls Church 8
Frankfurt am Main 8
Kish 8
Minneapolis 8
Monmouth Junction 8
San Antonio 8
San Jose 8
Traverse City 8
Tübingen 8
Washington 8
Amsterdam 7
Bologna 7
Totale 5.539
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.345
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 358
Vitamin D deficiency and supplementation in patients with aggressive B-cell lymphomas treated with immunochemotherapy 287
Risk factors for venous thromboembolism in patients with lymphoma requiring hospitalization 267
DNMT1-interacting RNAs block gene-specific DNA methylation 253
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 231
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 211
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 206
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 184
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 175
Venous Thromboembolism in Lymphoma: Risk Stratification and Antithrombotic Prophylaxis 172
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 169
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 166
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 159
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 155
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 154
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 140
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 136
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 134
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 134
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 133
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 130
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 128
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 127
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 124
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 124
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 121
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma. 118
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 116
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 115
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 113
Epigenetic changes in therapy-related MDS/AML 107
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 107
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 105
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 104
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 104
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 102
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 101
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 101
PU.1 and CEBPA expression in acute myeloid leukemia. 98
Progressive multifocal leukoencephalopathy in patients with follicular lymphoma treated with bendamustine plus rituximab followed by rituximab maintenance 98
Prognostic role of glutathione S-transferase polymorphisms in acute myeloid leukemia. 96
Outcome of therapy-related myeloid neoplasms treated with azacitidine 95
Intravascular large-B cell lymphoma: when lymphoma is suspected but routine diagnostic work-up is negative. 94
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma 94
DAP-kinase hypermethylation in the bone marrow of patients with follicular lymphoma. 93
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 92
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 91
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine. 90
Bax mutations are an infrequent event in indolent lymphomas and in mantle cell lymphoma 88
Primary pancreatic lymphoma in a patient with maturity onset diabetes of the young type 3 88
Mantle cell lymphoma relapsing at the lymphedematous arm 86
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI) 86
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma. 85
Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment 85
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 82
Glutathione-S-transferase genotypes influence prognosis in follicular non-Hodgkin's Lymphoma 80
Comorbidity assessment to determine prognosis in older adult patients with classical Hodgkin lymphoma 80
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 79
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 79
Azacitidine in a patient with myelodysplastic syndrome: Impact of switching from a 5-day to the approved 7-day dosing schedule 77
Negative prognostic value of glutathione s-transferase (gstm1 and gstt1) deletions in adult acute myeloid leukemia. 76
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 76
Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. 73
Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma 70
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 70
Four doses of unpegylated versus one dose of pegylated filgrastim as supportive therapy in R-CHOP-14 for elderly patients with diffuse large B-cell lymphoma 69
Chemoradiotherapy with temozolomide after high-dose methotrexate for primary CNS lymphoma: a multicenter phase I study of a response-adapted strategy 65
Burkitt lymphoma as fourth neoplasia in a patient affected by cowden syndrome with a novel PTEN germline pathogenic variant 65
In vitro Effect of Eltrombopag Alone and in Combination With Azacitidine on Megakaryopoiesis in Patients With Myelodysplastic Syndrome 59
PD-L1 expression in peripheral blood granulocytes at diagnosis as prognostic factor in classical Hodgkin lymphoma 59
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencing 58
Body mass index is not associated with survival outcomes and immune-related adverse events in patients with Hodgkin lymphoma treated with the immune checkpoint inhibitor nivolumab 55
Secondary Orbital and Intraocular Lymphoma Treated With Immunochemotherapy 51
Severe cmv infection after chemo-immunotherapy with dose- reduced bendamustine and rituximab in a mantle cell lymphoma old patient 47
Absence of structural mutations of the BAK gene in B cell lymphomas 45
Enhancing lymphoma diagnosis on core needle biopsies: Integrating immunohistochemistry with flow cytometry 34
Predicting time to treatment in follicular lymphoma on watchful waiting using baseline metabolic tumour burden 32
CAR-T Cell Therapy for Follicular Lymphomas 26
Novel Targets and Advanced Therapies in Diffuse Large B Cell Lymphomas 21
Aggiornamenti di Diagnostica Molecolare in Ematologia 18
Case of metastatic melanoma in bone marrow smear 18
Endoscopic Ultrasound-Guided Fine Needle Biopsy in the Diagnostic Work-Up of Deep-Seated Lymphadenopathies and Spleen Lesions: A Monocentric Experience 17
In vitro effect of eltrombopag alone and in combination with azacitidine on megakaryopoiesis in patients with myelodysplastic syndrome 16
May we routinely spare hippocampal region in primary central nervous system lymphoma during whole brain radiotherapy? 12
Treatment with Idelalisib in Patients with Relapsed or Refractory Follicular Lymphoma: The Observational Italian Multicenter FolIdela Study 10
Totale 11.294
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.306
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.306
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020833 0 0 0 0 0 172 131 66 128 107 134 95
2020/20211.182 42 99 46 102 116 116 125 34 110 89 259 44
2021/2022903 109 84 15 32 67 37 26 138 53 74 124 144
2022/20231.931 266 270 132 333 116 222 100 146 184 39 76 47
2023/20241.693 54 266 71 92 114 201 81 109 81 151 231 242
2024/20251.235 299 205 275 146 229 81 0 0 0 0 0 0
Totale 11.294